PBM Disclosure Requirements For Rx Switches Likely To Increase Costs – FTC
This article was originally published in The Pink Sheet Daily
Executive Summary
Legislation pending in California would likely to discourage generic substitution, thereby increasing consumers’ costs, FTC says. Commission finds that the bill is more likely to undermine competition than promote it.